1. Proteomic Research on the Therapeutic Properties of Medicinal Mushrooms
   Boris Jakopovic et al, 2023, Mushrooms with Therapeutic Potentials CrossRef
2. Uncovering the Anti-Lung-Cancer Mechanisms of the Herbal Drug FDY2004 by Network Pharmacology
   Ho-Sung Lee et al, 2021, Evidence-Based Complementary and Alternative Medicine CrossRef
3. PU-H71 (NSC 750424): a molecular masterpiece that targets HSP90 in cancer and beyond
   Sameh Saber et al, 2024, Frontiers in Pharmacology CrossRef
4. Deciphering the Precise Target for Saroglitazar Associated Antiangiogenic Effect: A Computational Synergistic Approach
   Swarna Dabral et al, 2023, ACS Omega CrossRef
5. Multiple Targeting of HSP Isoforms to Challenge Isoform Specificity and Compensatory Expression
   Kisho Ono et al, 2023, Chaperones CrossRef
6. Discovering Anti-Cancer Drugs via Computational Methods
   Wenqiang Cui et al, 2020, Frontiers in Pharmacology CrossRef
7. Targeting Endothelial Cell-Specific Molecule 1 Protein in Cancer: A Promising Therapeutic Approach
   He Zhang et al, 2021, Frontiers in Oncology CrossRef
8. Novel matrinic acid derivatives bearing 2‐anilinothiazole structure for non‐small cell lung cancer treatment with improved Hsp90 targeting effect
   Yiming Xu et al, 2022, Drug Development Research CrossRef
9. Functional redundancy of HSPA1, HSPA2 and other HSPA proteins in non-small cell lung carcinoma (NSCLC); an implication for NSCLC treatment
   Damian Robert Sojka et al, 2019, Scientific Reports CrossRef
10. Effect of silencing C-erbB-2 on esophageal carcinoma cell biological behaviors by inhibiting IGF-1 pathway activation
    Zhigao Niu et al, 2021, Journal of Cardiothoracic Surgery CrossRef
11. Targeted Inhibition of Hsp90 in Combination with Metformin Modulates Programmed Cell Death Pathways in A549 Lung Cancer Cells
    Adria Hasan et al, 2023, Applied Biochemistry and Biotechnology CrossRef